Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)

Starting soon

Conditions studied: Cardiac Sarcoidosis, Sarcoidosis of the Heart, Sarcoidosis With Myocarditis, Sarcoidosis, Cardiac

In brief

The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.

Key facts

Study ID

NCT07604220

Run by

Mayo Clinic

People needed

115

Starts

2026-07-01

Expected to finish

2028-07-01

Last updated by the study team

2026-05-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults ≥18 years.
• Patients referred to the Cardiac Sarcoid Clinic with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis.
• Undergoing FDG-PET as part of standard care.
• Ability to provide informed consent.

You may not qualify if…

• Inability to provide informed consent.

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.